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Background: Semaphorins are important molecules in embryonic development and 
multiple semaphorins have been identified as having key roles in immune regulation. 
To  date, there is little known about Semaphorin 4C (Sema4C) in immune biology. 
We report for the first time that Sema4C is inducible in human and murine B-cells and 
may be important for normal B-cell development.
Methods: Human tonsillar B-cells were studied following activation via anti-CD40 
antibodies in the presence or absence of representative Th1, Th2, and regulatory 
cytokines. Murine B-cells from WT and Sema4C−/− mice were similarly stimulated. B-cell 
phenotyping in WT and Sema4C mutant mice was performed by flow cytometry and 
lymphoid architecture was studied by immunohistochemistry. Sema4C expression and 
synapse formation were analyzed by confocal microscopy.
results: Gene array studies performed on human tonsillar B-cells stimulated to produce 
IgE revealed that Sema4C was among the top genes expressed at 24 h, and the only 
semaphorin to be increased under Th2 conditions. Validation studies demonstrated that 
human and murine B-cells expressed Sema4C under similar conditions. Sema4C−/− mice 
had impaired maturation of B-cell follicles in spleens and associated decreases in follicular 
and marginal zone B-cells as well as impaired IgG and IgA production. In keeping with a 
potential role in maturation of B-cells, Sema4C was expressed predominantly on CD27+ 
human B-cells. Within 72 h of B-cell activation, Sema4C was localized to one pole in a 
synapse-like structure, in association with F-actin, B-cell receptor, and Plexin-B2. Cell 
polarization was impaired in Sema4C−/− mice.
conclusion: We have identified a novel immune semaphorin induced in human and 
murine B-cells under Th2 conditions. Sema4C appears to be a marker for human mem-
ory B-cells. It may be important for B-cell polarization and for the formation of normal 
splenic follicles.
Keywords: semaphorin 4c, B-cells, immune synapse, Th2 responses
2Xue et al. Semaphorin 4C: A Novel Component of B-Cell Polarization
Frontiers in Immunology | www.frontiersin.org December 2016 | Volume 7 | Article 558
inTrODUcTiOn
Semaphorins have important roles in neural development and 
angiogenesis, and have recently emerged as key molecules in 
immune regulation (1). There are eight classes of semaphorins, 
of which five are expressed in vertebrate cells. The wide range 
of expression of these molecules and their binding partners, 
the plexins and neuropilins, contribute broadly to important 
homeostatic processes and especially the structural organiza-
tion of tissues (2). Semaphorins are characterized by a unique 
seven-branch propeller-like SEMA domain and are expressed 
as transmembrane molecules, GPI-anchored proteins, or are 
secreted in soluble forms (3).
B-lymphocytes are crucial players in host defense as producers 
of antibody and as antigen presenting cells. B-cells also initiate 
and potentiate allergic pathologies, by the production of IgE and 
the elaboration of key cytokines that enhance allergic inflamma-
tion (4). Our laboratory is particularly interested in the role that 
B-cells play in autoregulating Th2-mediated inflammation: we 
were the first to determine that human B-cells produced the key 
Th2 cytokine IL-13 (5), and identified signaling pathways related 
to expression of the IL-13R on human B-cells (6). In this context, 
we undertook to uncover novel molecules induced by activation 
of B-cells via Th2 cytokines, the initiating steps for class switching 
and production of IgE. Using expression profiling of Th2 stimu-
lated human tonsillar B-cells, we identified multiple genes that 
were previously known to influence IgE production. Semaphorin 
4C (Sema4C) was among the highest expressed genes following 
B-cell activation and was uniquely expressed at a much higher 
level than other members of the Semaphorin family.
There are no data to date that implicate Sema4C in immune 
biology, particularly in B-cells. Semaphorins have been observed 
to be involved in immune cell trafficking, apoptosis, cell growth, 
and cytokine production. Specifically, molecules including Sema 
3A, 4A and 4D, 6C, 7A, and 6D are involved in T-cell/dendritic-
cell interaction, integrin signaling, and T-cell proliferation (7, 8). 
Sema4D has been studied in the context of B-cell development, 
autoimmunity, and malignancy (9, 10). Sema4D KO mice have 
mild deficiencies in B-lymphocytes and antibody production. 
Sema4A and Sema4D deficient mice have been studied in models 
of allergic airways disease, but no specific effect has been found 
on B-cells in these models. In this study, we present data which 
demonstrate that Sema4C expression is a feature of B-cell activa-
tion specifically in Th2 responses.
Sema4C appears to be upregulated in maturing B-cells, and 
its expression was particularly restricted to human CD27+ cells, 
which denote memory B-cells. To further characterize the known 
functional protein association networks of Sema4C, we queried 
the STRING (Search Tool for the Retrieval of Interacting Genes/
Proteins) database (version 10.0, available at http://www.string-db.
org) (11), which examines known relationships in between genes, 
building networks of predicted functional associations based on 
gene ontology (GO) annotations, pathways, and domains (12). 
The gene network of Sema4C predicted by the STRING database 
displayed statistically significant enrichments for biological pro-
cesses including receptor localization to synapse, cell projection 
organization, semaphorin–plexin signaling pathways, plasma 
membrane components, and cell junctions. Using Sema4C−/− 
mice as well as human B-cells, we present evidence suggesting an 
important role for Sema4C in development of B-cell lymphoid 
follicles and in antibody production.
MaTerials anD MeThODs
subject selection and ethics statement
Children between the ages of 3–12 requiring tonsillectomy or 
adenoidectomy were randomly recruited from the otolaryngol-
ogy clinic at the Montreal Children’s Hospital as part of a study 
on B-cell responses to corticosteroids. At tonsillectomy, eligible 
children were not taking nasal or inhaled corticosteroids. Patient 
caregivers all provided written informed consent. Patients with 
immunodeficiency were recruited as part of the Canadian 
Primary Immunodeficiency Evaluative Survey (C-PRIMES) 
(13). All human subject protocols were approved by the Research 
Ethics Board of the McGill University Health Centre.
Transgenic and Wild-type Mice
Semaphorin 4C heterozygotes (Sema4C±) were bred on the 
C57BL/6 background (14). Sema4C± were interbred with 
resulting litters consisting of WT, Sema4C±, and Sema4C−/−. 
The Sema4C−/− mice were identified by genotyping as described 
previously (14), using a three-primer multiplex PCR with the 
following primers: TGGTGTGGCTTACCCTGTGCTTTG 
(genomic forward), AGAAAGGAGCCAGGTTGTTCTGCA 
(genomic reverse), and ACTTCCGGAGCGGATCTCAAACTC 
(vector reverse), which amplified a 620 bp wild type and a 430 bp 
mutant fragment (14). Littermate WT mice were used as control. 
All animals were housed in a specific pathogen-free environment, 
and all experiments were conducted in accordance with the 
regulations and standard guidelines of the Canadian Council on 
Animal Care, and were approved by the Animal Care Committee 
of the Research Institute of the McGill University Health Center.
human and Murine B-lymphocyte 
Preparation and culture
Human tonsils were minced and resuspended in wash medium 
consisting of RPMI 1640, 2% FBS (Hyclone, Logan, UT) with 
2  mM l-Glutamine, 50  U/mL penicillin, 50  µg/mL strepto-
mycin, 15  mM HEPES, and 0.5  µg/mL amphotericin B (Life 
Technologies, Mississauga, ON, Canada). The cells were overlaid 
on density-gradient separation medium (Lymphoprep, StemCell 
Technologies, Vancouver, BC, Canada) and centrifuged to 
isolate the mononuclear cells according to the manufacturer’s 
directions. These cells were mixed with human red blood cells 
and B-cells were purified using RosetteSep Human B-Cell 
Enrichment Cocktail (StemCell Technologies, Vancouver, BC, 
Canada). In some experiments, B-cells were further purified into 
CD27+ and CD27− subsets with the EasySep Human Memory 
B-Cell Isolation Kit (StemCell Technologies, Vancouver, BC, 
Canada). Human B-cells were cultured from 1 to 7  days in 
complete medium consisting of RPMI 1640 with 10% FBS, 
2mM l-Glutamine, 50 U/mL penicillin, 50 µg/mL streptomycin, 
1mM Sodium Pyruvate, and 15mM Hepes at 5 × 105 cells/mL. 
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The cells were stimulated with or without anti-CD40 (1 μg/mL, 
purified from the G28.5 cell line) (5), IL-4 (100  U/mL), IL-21 
(50 ng/mL) (Peprotech, Rocky Hill, NJ, USA) or IL-13 (100 U/
mL), IFN-γ (10 ng/mL), IL-12 (10 ng/mL), or IL-10 (10 ng/mL) 
(e-Biosource). Cells used for flow cytometry and RNA extraction 
were cultured in 24-well plates. Cells used for immunofluorescent 
microscopy were grown in eight-well slide chambers (BD Falcon, 
Mississauga, ON, Canada).
Peripheral blood mononuclear cells (PBMCs) were isolated 
from blood of healthy controls or patients with common variable 
immune deficiency (CVID) using Lymphoprep density gradient 
(StemCell Technologies, Vancouver, BC, Canada) according 
to the manufacturer’s instructions. Cells were either cytospun 
immediately, or grown in eight-well slide chambers in indicated 
culture conditions for 5  days, at 106  cells/mL, in complete 
medium with or without anti-CD40 (1 μg/mL), IL-4 (200 U/mL), 
and IL-21(50 ng/mL). Culture medium was refreshed after 72 h 
without adding cytokines.
Murine splenic B-cells were purified with the EasySep Mouse 
B Cell Enrichment Kit (StemCell Technologies, Vancouver, BC, 
Canada) following the manufacturer’s instructions. B-cells were 
plated either in six-well plates (Corning Costar, Corning, NY, 
USA) or eight-well culture slide chambers (Becton Dickenson, 
Mississauga, ON, Canada) at 5 × 105 cells/mL, stimulated with 
anti-CD40 antibodies (1  μg/mL, HM40-3, eBioscience, San 
Diego, CA, USA) in the presence of IL-4 and IL-21 (40 ng/mL, 
Prospec, East Brunswick, NJ, USA), in complete medium as 
indicated.
gene-expression Microarray analyses
RNA was extracted from tonsillar B-cells with TRIzol (Life 
Technologies). Samples used for microarray hybridization were 
further cleaned with RNeasy Mini silica-gel membrane columns 
(Qiagen, Hilden, Germany), and RNA quality and concentration 
were assessed by Bioanalyzer Microcapillary Electrophoresis 
(Agilent, Santa Clara, CA, USA). Samples had 260/280 absorb-
ance ratios > 1.8 and RNA Integrity Numbers (RIN) > 7.0. For 
samples used for RT-qPCR, RNA quality and concentration were 
assessed by Nanodrop spectrophotometry, and 260/280 absorb-
ance ratios were >1.8.
RNA samples were analyzed using Affymetrix GeneChip 
Human Genome U133 Plus 2.0 microarrays, which contain 
probe sets for 54,675 unique gene-expression sequences from 
the NCBI UniGene database, build 159. This provides genome-
wide expression coverage for 24,442 genes. Preparatory cRNA 
synthesis and labeling, microarray hybridization reactions, and 
array scanning were performed according to standard protocols 
at the McGill University and Génome Québec Innovation Centre 
Microarray core facility. Gene-expression data were subsequently 
processed using the Bioconductor packages oligo (15) for data 
read-in and normalization, and limma (16) for linear modeling 
and differential-expression statistics. Probe intensities were nor-
malized across all arrays by the robust multi-array average (RMA) 
algorithm (17). Differential gene expression of anti-CD40/IL-4-
treated B-cells versus unstimulated B-cells (control group) was 
calculated by linear modeling of the contrast and empirical Bayes 
sample variance shrinkage, followed by moderated t-tests with 
false discovery rate (FDR) correction (18). Results were expressed 
in terms of log(2)-fold change. Differentially expressed genes 
were defined as genes with log(2)-fold change greater than 2. All 
array data have been deposited in the GEO database, accession 
number GSE71810.
reverse-Transcription Quantitative Pcr
Quantification of the mRNA message coding for Semaphorin 4C 
(Sema4C) was performed by RT-qPCR. Sema4C primers were 
synthesized by Invitrogen (Carlsbad, CA, USA). TRIzol-extracted 
mRNA was prepared as above, followed by reverse transcription 
with DNase treatment. PCR reactions were performed using the 
Applied Biosystems 7500 Real-Time PCR system in a volume of 
10 µL per reaction, containing 1 μL of cDNA, 0.5 mM of each 
primer, and 5 μL of QuantiTect SYBR Green PCR mix (Qiagen, 
Mississauga, ON, Canada). The denaturation and amplification 
conditions for mRNA were 95°C for 15 min, followed by 55 cycles 
of PCR. Each cycle included denaturation at 95°C for 20 s, anneal-
ing at temperature indicated in Figure S1 in Supplementary 
Material for 20 s, and extension at 72°C for 30 s. The temperature 
transition rate was 20°C/s, except when heating at 72°C, when it 
was 5°C/s.
Detection of cell-surface Phenotype by 
Flow cytometry
Mouse spleen and lymph nodes were mechanically dissociated 
through a 90-mm mesh. Red blood cells were lysed using RBC 
Lysis Buffer (BioLegend, San Diego, CA, USA) according to the 
manufacturer’s instructions. Single cell suspensions were resus-
pended in PBS or complete medium. For flow cytometry, single 
cell suspensions were labeled with CD19-APC (6D5), CD21-
Pacific Blue (7E9), CD23-PE/Cy7 (B3B4), CD93-PerCP (AA4.1), 
IgD-APC/Cy7 (11-26c.2a), IgM-FITC (RMM-1), CD43-PerCP/
Cy5.5 (1B11), and CD138-PE (281-2) (BioLegend, San Diego, 
CA, USA) for 30 min at 4°C, followed by three washes with PBS. 
Data were acquired on BD LSR II Flow Cytometer and analyzed 
using FlowJo software version 10.0 for Macintosh.
immunohistochemistry and Microscopy
Confocal microscopy was used to assess expression of Sema4C 
and its co-localization with molecules on murine and human 
B-cells. Cells cultured in eight-well slide chambers were fixed 
with 4% formaldehyde. They were blocked with Protein Block 
(Dako, Burlington, ON, Canada) for 45  min, and stained with 
primary antibodies for 1 h, followed by incubation for 1 h with 
the secondary antibody at room temperature. Nuclei were stained 
with Hoechst 33342 (Life Technologies, Carlsbad, CA, USA) for 
15 min at room temperature, and photomicrographs were taken 
with a Zeiss LSM780 Laser Scanning Confocal microscope.
Spleens from WT and Sema4C−/− mice were snap-frozen, 
cryosectioned, and stained for histomorphometric measurement 
with ImageJ software (https://imagej.nih.gov/ij/).
Antibodies used included anti-mouse Sema4C (R&D 
Systems), anti-human Sema4C (R&D systems), anti-human 
Plexin-B2, anti-mouse Plexin-B2 (eBioscience), anti-human IgG 
(Acris), anti-sheep NL557, anti-sheep NL493 (R&D Systems), 
anti-mouse Alexa555 (Invitrogen), Phalloidin-Alexa Fluor 488 
FigUre 1 | expression profile of human B-cells identifies sema4c as 
a Th2-induced gene. (a) As part of a larger study on human allergic B-cell 
responses, human tonsillar B-cells were isolated by RosetteSep Human 
B-Cell Enrichment Cocktail, followed by anti-CD40 + IL-4 stimulation. After 
24 h, RNA was collected from stimulated cells. RNA samples were analyzed 
using Affymetrix GeneChip Human Genome U133 Plus 2.0 microarrays. M–A 
[minus log(2)-fold-change versus average log-expression] plot for the contrast 
of anti-CD40 + IL-4 versus unstimulated B-cells. Red lines indicate the 
threshold of twofold change for differential gene expression. The 10 most 
differentially expressed genes are labeled with their NCBI gene symbol (GEO 
accession number: GSE71810). (B) Real-time PCR was performed to 
validate the microarray results. Human Sema4C mRNA was detected in 
tonsillar B-cells stimulated with indicated stimulators for 24 h. mRNA samples 
were normalized to RPL27 as a reference gene. (c) Western blot was 
performed to confirm human Sema4C protein level in B-cells stimulated with 
indicated stimulators for 5 days. Means ± SEM, n = 10, *p < 0.05.
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(Cytoskeleton), Cholera Toxin B-Alexa Fluor 488 (Sigma), and 
anti-actin (Millipore).
lipid raft Protein Purification
Lipid rafts were isolated according to previously published proto-
cols (19–21). Stimulated and unstimulated isolated murine B-cells 
(108) were washed twice in cold serum-free RPMI 1640 and lysed 
in 600 μL of ice-cold TNE buffer (10 mM Tris, pH 7.5, 150 mM 
NaCl, and 5  mM EDTA) containing 1% Triton X-100, 2  mM 
Na3VO4, and protease inhibitors (Roche Molecular Biochemicals, 
Montreal, QC, Canada) on ice for 30 min. Cell lysates were mixed 
with an equal volume of 80% OptiPrep (Cosmo Bio, Carlsbad, 
CA, USA) in TNE and deposited in Beckman ultracentrifuge 
tubes. The samples were overlaid with 1.8 mL 35%, 1.8 mL 30%, 
1.8 mL 25%, and 0.6 mL 20% OptiPrep in TNE and centrifuged 
for 4  h at 45,000  rpm at 4°C. Eleven fractions (580  μL) were 
collected and aliquots of each fraction were mixed with 6× 
Laemmli buffer containing 6% 2-mercaptoethanol and heated 
for 5  min at 95°C. Samples were resolved by SDS-PAGE, and 
proteins were transferred onto polyvinylidene difluoride (PVDF) 
membranes (Bio-Rad, Mississauga, ON, Canada). After blocking 
with 5% BSA and 0.05% Tween 20 in TBS, the membranes were 
incubated with anti-mouse Sema4C antibodies (R&D Systems, 
Minneapolis, MN, USA), washed extensively, and subjected to 
chemiluminescent detection with HRP-conjugated anti-sheep 
IgG Ab using ECL (Bio-Rad, Mississauga, ON, Canada).
Detection of immunoglobulins by elisa
Total murine and human IgG and murine IgA from cell-culture 
supernatants or serum were measured by ELISA according 
to the manufacturer’s directions (Bethyl Laboratories, Inc., 
Montgomery, TX, USA). Serum and supernatant IgE were meas-
ured according to a previously published method (22).
statistical analysis
All data are presented as means  ±  SEM. Student’s t-test was 
performed for the quantitative assays. Statistical analysis was per-
formed with Prism 6.0 software (GraphPad, La Jolla, CA, USA). 
Mann–Whitney tests were performed to compare relative expres-
sion of Sema4C and IgG production between CVID subjects and 
controls. p-Values ≤ 0.05 were considered statistically significant.
resUlTs
expression Profile of human B-cells 
identifies sema4c as a Th2-induced gene
Highly purified B-lymphocytes were isolated from five atopic 
and five non-atopic randomly chosen children undergoing 
tonsillectomy as part of a study on B-cell responses to corticos-
teroids following exposure to Th2 cytokines. Purified B-cells were 
stimulated with anti-CD40 and IL-4 for 24  h, and mRNA was 
analyzed by gene chip analysis. Among the highest expressed 
genes at 24 h of stimulation, as detected by the Affymetrix U133 
Plus 2.0 array, was Sema4C (Figure 1A; Table 1). Sema4C was 
upregulated by 5.2-fold (log base 2) (Table  2) compared to 
unstimulated B-lymphocytes. This was detected equally in atopic 
and non-atopic children. Table 2 indicates changes from baseline 
for other known members of Semaphorin families. There were 
insignificant changes relative to control for Sema4A, B, D, and F. 
Indeed, as seen in Table 2, other Sema molecules, both soluble 
TaBle 2 | Differential expression of semaphorin family members.
gene symbol log(2)Fc average expression t p-Value FDr p-value B
SEMA4C 5.21704198 7.547023138 21.29194618 5.71E−11. 3.47E−07 14.97365834
SEMA4B −1.235599024 6.345794409 −5.3118569 0.000178806 0.005258783 0.830235823
SEMA4D −0.896259857 6.432564626 −4.467420803 0.000751329 0.013817334 −0.629351612
SEMA7A 0.403151491 6.68879853 2.173788882 0.05024346 0.23154331 −4.774256708
SEMA4A 0.38441167 6.470459825 1.141283825 0.275807098 0.603021278 −6.246174802
SEMA6A 0.29074576 4.455055136 2.122703445 0.055054311 0.244902321 −4.859130022
SEMA4F −0.262174692 4.964741139 −1.400057281 0.186578356 0.493907796 −5.935875619
SEMA6B −0.227714401 5.232972907 −1.912644868 0.079719927 0.306604318 −5.197925052
SEMA5B 0.181312147 3.816976678 1.187470534 0.257800641 0.583543996 −6.194386687
SEMA3A −0.160932883 2.718524137 −1.478466849 0.164803331 0.462079013 −5.832748049
SEMA3C 0.149658539 2.86694811 1.384716973 0.191108118 0.500118045 −5.955582839
SEMA6D 0.148505863 3.514224396 1.797559595 0.097195351 0.345193007 −5.375636572
SEMA3D 0.139936085 2.544893601 1.543396954 0.14843985 0.436662717 −5.744425555
SEMA6C 0.125123198 4.331553392 1.234448712 0.240442023 0.563560149 −6.140054909
SEMA3B 0.119732353 3.229057118 0.848524468 0.412596128 0.724463832 −6.534159586
SEMA3F 0.111764922 4.607073365 0.693642806 0.500988306 0.787113093 −6.656077523
SEMA5A −0.092673159 3.234224403 −0.901608551 0.384837035 0.703311324 −6.487356543
SEMA3E −0.049619278 2.151782378 −0.650234658 0.527677768 0.803799681 −6.686208382
SEMA4G 0.042891245 4.635360403 0.236850745 0.816729696 0.93973818 −6.878921767
SEMA3G 0.006477205 3.8604494 0.035343716 0.972381279 0.99116659 −6.908249422
Probe with highest differential expression is shown.
Log(2)FC: log(2)-fold change for contrast; average expression: average log2-expression for the probe over all arrays and channels; t: moderated t-statistic; p-value: raw p-value; FDR 
p-value: adjusted p-value using false discovery rate multiple comparisons correction; B: log-odds that gene is differentially expressed.
TaBle 1 | Top 10 differentially expressed genes in anti-cD40/il-4-treated B-cells versus unstimulated cells.
gene symbol log(2)Fc average expression t p-Value FDr p-value B
MAL 6.938443644 8.781046141 22.12378951 3.63E − 11 2.84E − 07 15.3252569
CCL17 6.105803764 7.680392611 16.5397378 1.11E − 09 2.28E − 06 12.50870126
IGH 5.935820046 7.673584573 12.06096389 4.14E − 08 1.94E − 05 9.187431123
LOC101928173 5.515918425 7.149173386 11.68877045 5.88E − 08 2.39E − 05 8.850838852
SEMA4C 5.21704198 7.547023138 21.29194618 5.71E − 11 3.47E − 07 14.97365834
TBC1D9 −5.036190035 5.841642242 −15.44879776 2.45E − 09 3.26E − 06 11.80732796
CYP26A1 4.930913543 7.459197163 7.998347059 3.54E − 06 0.000373054 4.810661778
BATF3 4.918258573 7.085415104 22.83952642 2.49E − 11 2.27E − 07 15.61211466
TFPI2 4.822924251 5.491276439 16.39571399 1.23E − 09 2.31E − 06 12.41949125
NFIL3 4.719930309 6.618679958 37.8227258 5.99E − 14 3.27E − 09 19.4033636
Log(2)FC: log(2)-fold change for contrast; average expression: average log2-expression for the probe over all arrays and channels; t: moderated t-statistic; p-value: raw p-value; FDR 
p-value: adjusted p-value using false discovery rate multiple comparisons correction; B: log-odds that gene is differentially expressed.
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and transmembrane, did not appear to be readily induced by 
Th2-mediated stimulation in human B-cells.
Th2 specificity of sema4c expression on 
human B-cells
We validated the expression of Sema4C on B-lymphocytes, 
including determination if the induction of Sema4C was a general 
function of B-cell activation or was Th2 specific. Using RT-qPCR, 
we found that there was minimal detectable Sema4C mRNA 
following stimulation with either anti-CD40 antibodies or IL-4 
alone. Indeed, baseline detection of Sema4C mRNA in human 
B-lymphocytes was low, with significant increases in expression 
following anti-CD40 + IL-4 stimulation (Figure 1B). The com-
bination of anti-CD40 and IL-13 induced expression of Sema4C 
to a similar degree as IL-4. Culture with anti-CD40 antibodies in 
the presence of Th1 cytokines IFN-γ or IL-12, or the T-regulatory 
cytokine IL-10 did not induce Sema4C mRNA (Figure S1 in 
Supplementary Material). Similarly, expression of Sema4C pro-
tein was restricted to the combination of anti-CD40 and IL-4 or 
IL-13 (Figure 1C) but not with anti-CD40 in combination with 
IFN-γ, IL-10, or IL-12 (Figure S1 in Supplementary Material). 
Increases in protein expression were seen with the combination 
of IL-4 and IL-21 as well, but IL-21 alone did not induce Sema4C 
protein in the absence of IL-4 (Figure 1C).
sema4c−/− Mice have Decreased B-cells 
in secondary lymphoid Organs and 
abnormal splenic Organization
To delineate if Sema4C played a role in B-cell development, 
we obtained Sema4C−/− mice bred on the C57BL/6 back-
ground (14). Viable Sema4C−/− mice did not have any overt 
phenotypic abnormalities, and did not display spontaneous 
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increased susceptibility to infection. There were no significant 
differences in the number of pro-, pre-, and immature B-cells 
detected in the bone marrow of Sema4C−/− compared to WT 
mice. Peripheral blood lymphocyte subsets were also similar in 
Sema4C−/− and WT (data not shown). However, Sema4C−/− mice 
had 30% fewer B-cells in spleens and lymph nodes compared 
to WT (Figures 2A,B), but exhibited no differences in number 
of CD4 T cells, CD4+ regulatory T cells, CD8 T cells, dendritic 
cells, macrophages, monocytes, eosinophils, or neutrophils 
(Table  3). We further evaluated B-cell subpopulations in the 
spleen, including marginal (CD19+CD21+IgMHighIgDLowCD23−C
D93−) and follicular B-cells (CD19+CD21−IgMlowIgDhighCD23+C
D93−) (23, 24). Both subpopulations were significantly reduced 
in Sema4C−/− mice (Figures  2C,D). Since the abnormalities 
in B-cells noted in Sema4C−/− mice appeared to be secondary 
maturation sites such as peripheral lymphoid tissues rather than 
in primary maturation sites like bone marrow, we investigated if 
this impaired maturation was associated with abnormalities in 
lymphoid morphology. As shown in Figures 2E,F, spleens from 
Sema4C−/− mice displayed markedly altered structures compared 
to WT. Sema4C−/− spleens had fewer discreet follicles and there 
was poor demarcation between T- and B-cell margins. Follicle 
size in Sema4C−/− mice was significantly larger and follicular 
appearance was markedly disorganized (Figures 2E,F).
sema4c−/− B-cells have impaired 
immunoglobulin Production
Serum IgG levels were comparable between naive Sema4C−/− and 
WT mice, while serum IgE was not detectable in both naive 
Sema4C−/− and WT mice (data not shown). We then investi-
gated if the absence of Sema4C would affect immunoglobulin 
production in cultured B-cells upon Th2 stimulation. B-cells 
isolated from spleens of Sema4C−/− or littermate WT mice were 
stimulated with anti-CD40 antibodies, in the presence of IL-4 and 
IL-21. IgG and IgA concentrations in supernatant were analyzed 
after 48 and 96 h of stimulation, and IgE was assessed after 7 days 
of stimulation. As shown in Figures 3A–C, Sema4C−/− B-cells had 
significantly decreased IgG and IgA production in response to 
stimulation, as well as lower levels of IgE compared to WT B-cells; 
however, IgM levels were comparable. Sema4C−/− B cell secreted 
significantly lower IgG at both 48 and 96 h post activation (Figure 
S3 in Supplementary Material), although the total number of class 
switched (CD19+sIgM−sIgD−) B-cells in culture appeared not to 
differ significantly.
sema4c associates with F-actin during 
Murine B-cell Maturation
In order to predict potential roles for Sema4C in B-cell differ-
entiation, we compared anti-CD40/IL-4-treated tonsillar B-cells 
versus unstimulated cells using the Database for Annotation, 
Visualization and Integrated Discovery (DAVID) which 
provided functional annotation clustering of differentially 
expressed genes (version 6.7, available at https://david.ncifcrf.
gov/) (25, 26). Sema4C was placed in three enrichment clusters 
(Table S2 in Supplementary Material): “membrane,” “intrinsic 
to membrane,” and “immunoglobulin domain.” Because we 
observed that follicular development in Sema4C−/− mice was 
highly abnormal, and DAVID analysis predicted that Sema4C 
should be an integral component of B-cell membrane dynam-
ics, we therefore evaluated the pattern of membrane expression 
of Sema4C. Of note, to date no reliable Sema4C antibodies for 
flow cytometry have been produced. However, suitable anti-
bodies exist for immunohistochemistry and Western blotting. 
Sema4C was detected on WT B-cells at 24 h following activation 
with anti-CD40 + IL-4 + IL-21, but not on Sema4C−/− B-cells 
(Figure  4A, top and bottom panels). Sema4C was distributed 
uniformly along the membrane of B-cells at 24  h. However, 
by 72  h, Sema4C expression was strongly localized to a pole 
or synapse-like structure (Figure 4A, middle panel). Immune 
synapses are areas which include clusters of signaling complexes 
and adhesion molecules, critical for organization, and dif-
ferentiation of B-cells (27). As most immune synapses contain 
F-actin as an anchor to the coalesced molecules, we costained 
for F-actin at 24 and 72  h. As seen in Figure  4, Sema4C and 
F-actin at first colocalize uniformly along the membrane of 
stimulated B-cells at 24 h, then, following cell polarization, colo-
calize in a synapse-like structure at 72 h. Importantly, not only 
was Sema4C protein not present in B-cell synapses following 
activation in Sema4C−/− mice, but B-cells exhibiting polarization 
were significantly less frequent (Figure  4). In those cells that 
did polarize and express a synapse-like structure, staining of 
F-actin appeared more diffuse and less organized (Figure 4A, 
lower panel). Taken together with the disrupted architecture 
found in Sema4C−/− spleens, these data imply that Sema4C may 
be important in B-cell polarization and the formation of B-cell 
synapses during follicular development.
Since lipid rafts frequently contain the proteins and surface 
molecules that migrate to synapses (19–21), we evaluated if 
Sema4C and lipid rafts colocalized in B-cells using immunofluo-
rescent staining. Lipid rafts were identified by Cholera Toxin B 
that binds the lipid raft constituent ganglioside GM1. Figure 4B 
demonstrates a cluster of four B-cells with the lipid raft fraction 
coalesced toward a pole between the cells. Additionally, Cholera 
Toxin B staining and Sema4C colocalized on the activated B-cells. 
This association was confirmed by isolating lipid raft proteins 
using gradient centrifugation and probing with anti-Sema4C 
antibodies (Figure 4C).
sema4c colocalizes with F-actin and 
Other Key synaptic Molecules Following 
human B-cell activation
Having established the association of Sema4C and F-actin in 
murine B-cells, we studied whether expression of Sema4C and 
colocalization with polarized F-actin was also a feature of human 
B-cell activation. Tonsillar B-lymphocytes were cultured in slide 
chambers for up to 5 days and Sema4C was visualized in situ (5). 
Similar to murine cells, after 24 h of activation with anti-CD40, 
IL-4, and IL-21, Sema4C was present in a perimembranous 
staining pattern. This was also observed with anti-CD40 + IL-4 
but not with anti-CD40 alone or anti-CD40 +  IFN-γ (data not 
shown). Upon stimulation for 120  h, B-cells exposed to anti-
CD40 + IL-4 + IL-21 exhibited expression of Sema4C localized 
FigUre 2 | sema4c−/− mice have decreased B-cells in secondary lymphoid organs and abnormal splenic organization. (a–D) Sema4C−/− mice had 
decreased B-cells in secondary lymphoid organs. Total B cell counts in spleen (a) and cervical lymph nodes (B), follicular B-cells (c) and marginal zone B-cells (D) 
from naïve Sema4C−/− or littermate WT mice were determined by flow cytometry. B-cells were defined as CD19+CD3−, follicular B-cells: 
CD19+CD93−CD21−CD23+IgMLowIgDHigh, marginal zone B-cells: CD19+CD93−CD21+CD23−IgMHighIgDLow. (e,F) Sema4C−/− mice exhibit abnormal secondary lymphoid 
organ follicular structure. (e) Size of splenic follicles in naïve Sema4C−/− or WT mice, measured by ImageJ. Each dot indicates one follicle and follicles were randomly 
selected from five different mice. n = 5. (F) Representative immunofluorescence images of spleens from naïve Sema4C−/− or WT mice stained for CD19 (red), CD3 
(green), and nuclei (blue). Data shown are representative of five mice. Images showing Sema4C−/− mice had larger follicles as well as poor demarcation between T- 
and B-cell margins. Scale bar: 200 μm.
7
Xue et al. Semaphorin 4C: A Novel Component of B-Cell Polarization
Frontiers in Immunology | www.frontiersin.org December 2016 | Volume 7 | Article 558
FigUre 3 | sema4c−/− mice demonstrate impaired in vitro immunoglobulin production. Splenic B-cells were isolated from WT and Sema4C−/− mice, then 
stimulated with anti-CD40 antibodies in the presence of IL-4 and IL-21, at the density of 106 cells/mL. IgG (a) and IgA (B) concentrations in the supernatant were 
measured after 4 days of culture by ELISA. IgE (c) concentrations were similarly measured by ELISA after 7 days of culture. Means ± SEM, three independent 
experiments. Each dot represents one individual mouse. *p < 0.05, ***p < 0.001.
TaBle 3 | analysis of cell populations in WT and sema4c−/− naive mice in spleens and cervical lymph nodes.
spleen (×106) lymph node (×104)
WT sema4c−/− WT sema4c−/−
Macrophages 0.66 ± 0.01 0.86 ± 0.23 2.20 ± 0.30 1.70 ± 0.98
Monocytes 2.89 ± 0.31 3.54 ± 0.80 3.08 ± 0.38 3.82 ± 0.25
Dendritic cells 0.21 ± 0.03 0.18 ± 0.05 0.47 ± 0.25 0.15 ± 0.11
Neutrophils 0.02 ± 0.01 0.02 ± 0.01 – –
Eosinophils 0.07 ± 0.01 0.10 ± 0.02 – –
CD4+ Foxp3− T cells 15.37 ± 1.37 23.14 ± 13.73 4.37 ± 1.46 4.27 ± 1.92
CD4+ Foxp3+ T cells 1.55 ± 0.07 1.94 ± 0.08 0.43 ± 0.13 0.44 ± 0.14
CD8 T cell 10.32 ± 0.62 11.82 ± 0.46 3.24 ± 0.94 2.76 ± 0.88
Absolute numbers are presented as indicated.
Definition of cell phenoytpes: macrophage: CD3−CD19−CD11b+F4/80+; monocytes: CD3−CD19−Ly6C+Ly6G−CD11b+F4/80−; dendritic cells: CD3−CD19−CD11c+MHCII+; 
neutrophils: CD3−CD19−Ly6C+Ly6G+CD11b+F/480−; eosinophils: CD3−CD19−CD11b+SiglecF+; CD4+Foxp3+ T cells: CD3+CD4+CD19−CD11b−Foxp3+; CD4+Foxp3− T cells: 
CD3+CD4+CD19−CD11b−Foxp3−; CD8+ T cells: CD3+CD4−CD19−CD11b−CD8+.
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to one pole of the B-cells (Figure 5, bottom panel). Additionally, 
as in murine B-cells, Sema4C colocalized with F-actin accumula-
tion. In the absence of Th2 cytokines, there was little expression of 
Sema4C, polarization or synapse formation (Figure 5, top panel).
The primary binding partner for Sema4C, Plexin-B2, is con-
stitutively expressed on a high percentage of resting B-cells in a 
diffuse membranous pattern (Figure 6A). Following 72–120 h of 
stimulation, Plexin-B2 and Sema4C were also colocalized within 
the B-cell clones similar to F-actin (Figure 6A, bottom panel). 
The approximation of Sema4C and Plexin-B2 at a single pole of 
activated B-cells was rarely seen in unstimulated B-cells or in the 
absence of Th2 cytokines (Figure  6A, top and middle panels). 
The synaptic structure that we identified also included the B-cell 
receptor (BCR) which is expressed broadly on the membrane 
in resting cells but is found in the synapse-like pole colocalized 
with Sema4C following 3–5 days of activation (Figure 6B, bottom 
panel). In contrast, CD20 was not found to colocalize into the 
pole but remained diffusely distributed in the membrane (data 
not shown). In summary, Sema4C is an integral member of the 
molecules that coalesce to form a synapse-like structure on the 
surface of B-cells following activation and polarization under Th2 
conditions in both murine and human B-cells.
sema4c is Preferentially induced on 
cD27+ human Memory B-cells
We next examined the expression of Sema4C protein within 
specific populations of activated B-cells. Following anti-
CD40 + IL-4, Sema4C expression was detected on approximately 
10–15% of cultured B-cells after 72 h. The combination of anti-
CD40 + IL-4 + IL-21 induced purified B-cells to express Sema4C 
at 72 h (Figure S2 in Supplementary Material). The combination 
of anti-CD40 +  IL-4 +  IL-21 mediated activation appeared to 
be specific for induction of Sema4C, as neither BCR stimulation, 
with or without added Th2 cytokines, nor toll-like 9 receptor 
stimulation with CpG sequences, increased Sema4C expression 
(data not shown).
The induction of maximal Sema4C expression by the combi-
nation of anti-CD40 + IL-4 + IL-21, which mimics signals from 
FigUre 4 | Murine sema4c associates with F-actin during B cell maturation. (a) Isolated WT and Sema4C−/− murine splenic B-cells were stimulated with 
anti-CD40 antibodies, IL-4, and IL-21 in slide chambers and Sema4C (red), F-actin (green), and nuclei (blue) were stained and analyzed by confocal microscopy. 
Upper panel: 24 h, depicting perimembranous staining of Sema4C and F-actin. Middle panel: WT B-cells, following 72 h of culture, Sema4C and F-actin colocalize 
toward one pole of the cell. Lower panel: Sema4C−/− following 72 h of culture. No evidence of Sema4C staining and F-actin does not form a normal polar structure. 
Scale bar: 10 μm. Histogram: percentage of B-cells expressing a synapse-like structure at one pole after 72 h of expression, comparing WT and Sema4C−/− mice. 
n = 3 experiments, total cells counted 3–4 fields with 25 cells in total. (B). Sema4C localizes within lipid rafts. WT B-cells were stimulated with anti-CD40 antibody, in 
the presence of IL-4 and IL-21. After 72 h, B-cells were double stained with anti-Sema4C antibody (red) and Cholera Toxin B-Alexa Fluor 488 (green). 
Representative images showing four cells in a cluster with synapse toward the center of the cluster. White arrows indicate one cell, with both the lipid raft fraction 
and Sema4C located at a pole in the center of the four indicated B-cells. Scale bar: 50 μm. (c) B-cells stimulated as in (B) were lysed and gradient centrifuged as 
described in Section “Materials and Methods.” Sema4C was primarily detected in the lipid raft layer (right). Each image represents three independent experiments.
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T-follicular helper cells, suggested that Sema4C expression was 
likely to be on mature, memory B-cells. To determine if this was 
indeed the case, we fractionated human B-cells into memory and 
naïve populations, using positive selection for CD27, a marker of 
human memory B-cells. CD27+ and CD27− B-cells were stimu-
lated with anti-CD40 in the presence or absence of IL-4 + IL-21 
(28). Direct visualization of Sema4C protein expression by 
immunohistochemistry indicated that membranous expression 
of Sema4C was observed in stimulated CD27+ B-cells, with sig-
nificantly fewer CD27− B-cells expressing Sema4C (Figure 7A). 
As shown in Figure  7B, direct microscopic enumeration of 
Sema4C+ cells greatly favored CD27+ cells over the CD27− cell 
population. This suggests that Sema4C induction is a feature of 
Th2-mediated memory B-cell activation.
sema4c induction is Decreased in 
Patients with impaired immunoglobulin 
Production
To determine if there was an association between Sema4C and 
impaired B-cell development, we evaluated Sema4C expression 
in individuals with CVID from a well characterized cohort 
participating in the C-PRIMES database study for primary 
immune deficiency (13). Baseline Sema4C mRNA expres-
sion was significantly lower in PBMCs from CVID subjects 
compared to healthy controls (Figure 8A). PBMCs from CVID 
subjects and controls were then stimulated in  vitro using anti-
CD40 +  IL-4 +  IL-21, to promote B-cell development and IgG 
production as well as Sema4C protein expression. CVID subjects 
had impaired IgG production in culture (mean 1.12 mg/L ± 1.94 
FigUre 6 | human sema4c colocalizes with Plexin-B2 and Bcr. 
Human B-cells isolated from tonsil were stimulated with anti-CD40 in the 
presence or absence of IL-4 and IL-21 for 5 days in slide chamber. 
(a) Representative images of cells stained with anti-Sema4C antibodies 
(green), anti-Plexin-B2 antibodies (red), and a nuclear stain (Hoechst 33342, 
blue). Upper panel: unstimulated tonsillar B-cells showing constitutive 
Plexin-B2 staining but minimal Sema4C; middle panel: anti-CD40 antibodies 
for 5 days indicating minimal Sema4C expression but no Plexin-B2; and lower 
panel: anti-CD40 antibodies + IL-4 + IL-21 indicating optimal Sema4C 
expression and organization into a synapse-like structure colocalizing with 
Plexin-B2. (B) Representative image of cells stained with anti-Sema4C 
antibodies (green), anti-BCR antibodies (red), and a nuclear stain (Hoechst 
33342, blue). Upper panel: unstimulated tonsillar B-cells showing constitutive 
BCR staining but minimal Sema4C expression; middle panel: anti-CD40 
antibodies for 5 days indicating minimal Sema4C expression; and lower panel: 
anti-CD40 antibodies + IL-4 + IL-21 indicating optimal Sema4C expression 
and organization into a synapse-like structure colocalizing with BCR.
FigUre 5 | human sema4c associates with F-actin on activated 
B-cells. Human B-cells were isolated from tonsils and stimulated with 
anti-CD40 antibodies ± IL-4 and IL-21 for 5 days in slide chambers. Cells 
were stained with anti-F-actin antibodies (red), anti-human Sema4C 
antibodies (green), and a nuclear stain (Hoechst 33342, blue). Upper panel: 
CD40 antibodies; lower panel: CD40 antibodies + IL-4 + IL-21. Sema4C 
expression and organization into a synapse-like structure is optimally 
achieved with anti-CD40 + IL-4 + IL-21 but not with anti-CD40 alone. 
Representative images of three independent experiments.
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SD mg/L) compared to controls (mean 6.31  mg/L ±  5.62 SD 
mg/L, p <  0.001). As observed with tonsillar B-cells, PBMCs 
from healthy controls demonstrated Sema4C protein expression, 
polarization, and formation of the synapse-like structure in 
association with the BCR following 5  days of stimulation with 
anti-CD40 + IL-4 + IL-21 (Figure 8B). CVID subjects showed 
some membranous expression of Sema4C protein; however, there 
was little colocalization with BCR-IgG, and polarization and 
synapse-like structures were absent, similar to that observed in 
Sema4C−/− mice. These data suggest that impaired polarization 
and formation of Sema4C-containing synapse-like structures 
may be seen of a subset of CVID patients, which may play a role 
in their diminished Ig production.
DiscUssiOn
Optimal B-lymphocyte development and production of antibod-
ies require coordination, contact and communication between 
B-cells within clones, and B and T cells within follicles (29). 
Although molecules such as CD40 and CD40L, integrins, and 
other costimulatory molecules have been extensively studied, 
there are still gaps in the understanding of the molecules which 
mediate exchanges of information by B-cells (30). Our laboratory 
studies regulatory events in B-cells related to antibody produc-
tion, immune defects, and severe allergic inflammation (5, 22, 
31–34). We have found a novel player which serves a key role 
in the organization of B-cell follicular structures and optimal 
antibody production. Semaphorin 4C appears to be required 
for cellular polarization, and is a component of B-cell synapse 
formation specifically induced following Th2 cytokine-mediated 
activation. This appears to be required for normal B-cells dif-
ferentiation (14).
Using B-cells purified from human tonsils to study events 
related to induction of IgE-forming B-cells, gene array studies 
revealed that Sema4C was among the most highly induced genes 
following 24 h of stimulation (Table 1). As with other class 4 Sema 
family members, Sema4C includes an extracellular Sema domain, 
an Ig-like domain, a transmembrane region, and a proline rich 
intra-cytoplasmic domain (35). Sema4C binds with high affinity 
to Plexin-B2, a crucial molecule for neural tube closure and brain 
development in embryogenesis.
Although Sema4C is not the first semaphorin to be found 
expressed on B-cells, other members of the Sema family such as 
4D are constitutively expressed (7) and in our hands were not 
FigUre 7 | sema4c is preferentially induced on memory B-cells. 
Isolated human tonsillar B-cells were purified into CD27+ and CD27− 
populations by magnetic bead separation. (a) Representative 
immunofluorescence staining image showing Sema4C protein level in CD27+ 
(upper panel) or CD27− (lower panel) B-cells stimulated with CD40L ± IL-4 
and IL-21 for 5 days. Green: Sema4C, blue: nucleus. (B). Histogram 
summarizing the percentage of Sema4C expressing B-cells among total cells 
stimulated under indicated conditions. Cells were counted by microscopy by 
two independent evaluators and means compared. Inter-rater reliability 
showed a variance of <10%. *p < 0.05, n = 8 experiments.
FigUre 8 | Patients with common variable immunodeficiency (cViD) 
have lower sema4c mrna and protein expression and impaired 
synapse-like pole formation. (a) Peripheral blood mononuclear cells 
(PBMCs) were purified and mRNA extracted. Sema4C mRNA expression 
was evaluated by semi-quantitative RT-PCR. CVID subjects showed 
significantly lower basal Sema4C mRNA expression (compared to the 
GAPDH reference gene) than healthy controls without immune deficiency 
(HC) (*p = 0.04, Mann–Whitney test). (B) PBMC from healthy controls and 
subjects with CVID were stimulated for 5 days in vitro with anti-CD40 
antibodies + IL-4 + IL-21. Representative confocal microscopy: HC 
demonstrated increased expression of Sema4C as well as synapse-like 
structure formation colocalizing Sema4C with BCR. The two lower panels 
demonstrate two independently chosen CVID subjects showing membranous 
Sema4C protein expression and no synapse-like structure formation following 
5 days of stimulation with anti-CD40 + IL-4 + IL-21.
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increased by Th2 activation (Table 2). Sema4C is therefore the 
first semaphorin specifically induced on B-lymphocytes under 
Th2 conditions, yet it is among the least explored semaphorins 
in immune biology. Related family members such as Sema4D 
and Sema4A have been studied in B-lymphocytes (8, 10), 
T-lymphocytes (36, 37), and dendritic cells (8, 38). Mice with a 
selective KO of Sema4D demonstrated poor recall responses to 
antigens and impaired immunoglobulin production. Interaction 
of Sema4D-expressing CD5+ B-cells or leukemic-B-cells with 
Plexin-B1-expressing cells led to improved tumor survival. 
Sema4D is also involved in interaction between T cells and B-cells 
(39, 40), and in mediating endothelial cell migration (41), while 
Sema4A is known to activate regulatory T-lymphocytes and 
cytotoxic T cells (42–44). Interestingly, Sema4A and 4D utilize 
specific plexins as their primary non-hematopoietic receptors, 
but appear to interact with different binding partners in the 
immune system. Sema4A may interact with T-lymphocytes via 
TIM-2, and Sema4D, also known as CD100, is able to diminish 
BCR signaling and decrease B-cell growth response via interac-
tion with CD72 (37). Both T and B-cells can express Sema4D and 
CD72, potentially leading to mutual regulation signals. To date, 
no accessory ligands have been determined for Sema4C (2).
B-cell development is predicated upon normal communica-
tion between T and B lymphocytes, as well as between B-cells in 
lymphoid follicles. The points of communication between cells 
are known as immune synapses (45). The concept of the immune 
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“synapse” has been borrowed from neuroscience, as it describes 
a defined interface that allows for transmissions of signals 
between cells. The signals are mediated by cell–cell contact and/
or soluble factors, via neurotransmitters, cytokines, hormones, 
or microvesicles. There is much known about the role of T-cell 
immune synapses in T and B cell interaction B-cell synapses for 
antigen presentation (29, 46). As suggested by DAVID (Table S2 
in Supplementary Material) and STRING analysis (Table S3 in 
Supplementary Material) we demonstrate that following Tfh-
mediated activation, Sema4C is a component in B-cell polarization 
and B-cell synapses, along with F-actin, the BCR, and Plexin-B2. 
The paucity of well-defined synapses following B-cell activation 
in the Sema4C−/− mouse compared to WT may be an important 
contributor to the lack of formation of normal splenic follicles, as 
well as decreased numbers of MZ and FOB which were seen in 
Sema4C−/−. In keeping with altered B cell differentiation, produc-
tion of immunoglobulin in vitro is also impaired, suggesting that 
cell–cell communication within expanding B-cell clones may be 
malfunctioning.
The optimal conditions for Sema4C upregulation are ligation 
of CD40 in the presence of IL-4 and IL-21. Ligation of the BCR, 
of toll-like receptors or other cytokine combinations were unable 
to upregulate Sema4C (Figure  1; Figure S1 in Supplementary 
Material and data not shown). This specificity suggests that a 
principle contact leading to enhanced expression of Sema4C 
on B-cells is via T-follicular helper cells. The primary difference 
between Tfh and Th2 cell cytokine production is the presence of 
IL-21 in the Tfh, and the absence of most Th2 cytokines with the 
exception of IL-4 and IL-21 (47, 48). The interaction between Tfh 
and B-cells is at the T and B-interface of lymph node follicles. 
This interaction is tightly regulated by chemokines, is crucial for 
the productive development of both the Tfh cells and antibody 
secreting B-cells. Crotty (49) demonstrated that the interaction 
between B-cells and Tfh is dependent on antigen presentation by 
B-cells. This may be impaired in mice deficient in Sema4C, as 
BCR is a component of the immune synapse that forms following 
CD40 ligation + IL-4 + IL-21. Incomplete focusing of the BCR 
may lead to decreased antigen presentation, incomplete signal-
ing, and decreased Tfh cell number and function (49). These are 
important aspects for exploration in our future studies.
The most striking immunological findings in mice deficient 
in Sema4C are related to B-cell differentiation in the spleen. 
Specifically, the splenic architecture revealed impaired T-cell/B-
cell demarcation, leading to increased follicular size and unusual 
organization. This disruption in follicular architecture has also 
been seen in RELB deficient mice (50). This can be due to a role 
for Sema4C directly via interaction with Plexin-B2 expressed 
on T cells. The potential consequences of impaired B-cell–T-cell 
communication and follicular abnormalities include diminished 
subsets of follicular and marginal zone B-cells, which we observed 
in Sema4C−/− mice. We are using B-cell specific Sema4C−/− mice 
to study if this molecule is required for Tfh activation and normal 
humoral responses and response to inhaled allergens.
Interaction between Plexin-B2 and a semaphorin ligand in the 
process of B-cell maturation was suggested by Yu et al. (51), who 
determined that Plexin-B2 was expressed by murine and tonsil-
lar germinal center B-cells. Our data suggest that signaling via 
Sema4C and Plexin-B2 in lymphoid tissue thus may be needed 
for normal Ig production. In our studies, Sema4C was detected 
almost exclusively in the CD27+ fraction on human B-cells, the 
subset that include predominantly memory B-cells and plasmab-
lasts (52). It is unknown if Sema4C is required for the induction of 
B-cell memory, but productive GC interactions requiring synapse 
formation between B and Tfh cells appear to be a prerequisite for 
normal B-cell memory (53, 54). While we are in the process of 
evaluating memory and antigen responses in the murine system, 
we present intriguing preliminary data in individuals with CVID, 
specifically those with very low memory B-cells and associated 
poor antibody production, who have impaired upregulation of 
Sema4C mRNA and impaired synapse formation, analgous to 
Sema4C−/− mice.
In conclusion, we have determined that a key molecule in the 
developing nervous system, previously not known to be expressed 
or functional in immune biology, can be induced in human 
B-lymphocytes under highly specific conditions. We report 
expression of Sema4C is induced in human B-lymphocytes, and its 
expression is found primarily on mature human B-lymphocytes, 
predominantly on CD27+ B-cells. Moreover, the expression of 
Sema4C appears to be important for normal B-cell polarization 
following Th2-mediated activation as well as part of a synapse-
like structure which includes Plexin-B2. This is the first time 
Sema4C has been described in human B-cells, and our studies 
suggest the importance of Sema4C in cell–cell communication 
regulating B-cell differentiation.
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